Papers nuevos sobre Tratamiento del cáncer
19 papers nuevos sobre tratamiento del cáncer en los últimos 7 días, dentro de Medicina y salud. Acá están los 19 que Pipette considera más valiosos, con el resultado principal en palabras de sus autores.
Lo mejor de la semana
Multigene-engineered fibroblast-derived biomimetic vesicles for cancer multimodal targeting and immune reprogramming
Using this platform, we construct multigene-engineered fibroblast-derived nanovesicles (X-Fb-MNVs) coexpressing critical chemokine receptor CXCR4 and adhesion ligand iRGD, as well as PD-1 and CD47 protein, which achieved robust and broad-spectrum tumor targeting across breast, liver, pancreatic, and colon cancer PDX models.
Revista con revisión por paresAfirmaciones fuertes, leer con cuidadoUso en el mundo realCytotoxic drugs and bispecific T cell engagers synergize to rewire host immunity and elicit polyclonal antitumor T cell responses
Here we show that tumor-associated antigen (TAA)-targeted CD28 bispecific antibodies (TAAxCD28) convert cytotoxic agents into drivers of durable antitumor immunity.
Revista con revisión por paresAfirmaciones fuertes, leer con cuidadoUso en el mundo realAlbumin-bound paclitaxel–induced stromal reprogramming drives resistance to neoadjuvant chemotherapy in patients with pancreatic cancer
These findings map chemotherapy-induced CAF plasticity, reveal a TMEM100-AREG axis of resistance, and highlight TMEM100 + CAFs as a promising target to sensitize PDAC to neoadjuvant treatment.
Revista con revisión por paresUso en el mundo realThe contribution of Neanderthal ancestry to cancer risk
Twelve cancers have multiple Neanderthal alleles significantly associated with variation in risk.
PreprintIzalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial
Conclusions and Relevance Izalontamab brengitecan significantly improved PFS and OS vs chemotherapy in patients with recurrent or metastatic ESCC whose disease had progressed after first-line treatment.
Revista con revisión por paresUso en el mundo realPartially functional hypomorphic missense variants in BRCA2 are reduced penetrance pathogenic variants
Here we show that 70 candidate hypomorphic missense variants in the DNA-binding domain of BRCA2 reduce homologous recombination DNA repair activity and endogenous cell survival, decrease RAD51 foci formation, and increase sensitivity to Poly(ADP-ribose) polymerase inhibitors.
Revista con revisión por paresUso en el mundo realExciton binding regulation in oxygen-independent tumor photooxidation enables synchronous photoluminescence for cancer theranostics
This work establishes exciton management as a universal design principle to synchronize photooxidation and photoluminescence and supports the development of organic semiconductors for cancer theranostics.
Revista con revisión por paresAfirmaciones fuertes, leer con cuidadoUso en el mundo realIntegrated Genomic and Transcriptomic Profiling Reveals Distinct Biological Programs and Therapeutic Opportunities in Cancer of Unknown Primary
Together, these findings provide a molecular framework for understanding CUP heterogeneity and support therapeutic stratification by both ToO predictions and tumor-specific molecular alterations.
PreprintUso en el mundo realWhole-genome sequencing enables improved AML diagnostics and refines assessment of TP53 allelic state and complex karyotype
Collectively, these results support paired tumor-normal WGS as a single comprehensive assay well suited for AML diagnostics according to current classification and risk-stratification systems, while refining assessment of TP53 allelic state and karyotypic complexity.
PreprintUso en el mundo realNormalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Progression-free survival was longer in Dato-DXd-treated (median 7.2 versus 4.0 months; hazard ratio 0.40, 95% confidence interval 0.25–0.64) but not docetaxel-treated (median 4.1 versus 4.4 months; hazard ratio 0.94, 95% confidence interval 0.59–1.49) patients with TROP2 NMR-positive versus TROP2 NMR-negative samples (treatment by biomarker status interaction P = 0.0098), indicating that TROP2 NMR may be a predictive biomarker for Dato-DXd.
Revista con revisión por paresUso en el mundo realGenome-wide association meta-analysis of atrophic gastritis reveals anti H. pylori IgG serostatus dependent associations and genetic overlap with gastric cancer
They highlight epithelial and mucus barrier-related pathways in seropositive AG/SAG and immune-related pathways in seronegative cases, while also providing evidence of a shared genetic basis between AG and GC.
PreprintCancer risk and survival outcomes in germline POT1 variant carriers
Conclusion: POT1 is a cancer susceptibility gene associated with a moderate (1.5-3.5-fold) increased cancer risk.
PreprintUso en el mundo realOsimertinib, platinum, and etoposide for patients with metastatic EGFR / TP53 / RB1 -mutant lung cancers at risk for histological transformation
Despite the addition of SCLC-directed chemotherapy, nearly half of patients (5 of 11) underwent SCLC transformation, with median progression-free survival of 11 months and overall survival of 33 months.
Revista con revisión por paresUso en el mundo realDecoding cancer therapy resistance through advanced 3D organoid systems
Here, we review the applications of 3D cancer models, including scaffold-free spheroids, patient-derived organoids (PDOs) biobanks, and microphysiological systems (MPSs), in drug resistance modeling and personalized therapy.
Revista con revisión por paresUso en el mundo realHierarchical Graph Learning with Multimodal Distillation for Breast Cancer Survival Prediction
In this paper, we propose HEAL-Surv, a teacher-student framework that uses both modalities during training to predict five-year net disease-specific survival (DSS) from clinical variables and molecular profiles at inference.
PreprintUso en el mundo realCONSORTiUM-IO: A Phase 1 Study Evaluating VE800 Plus Nivolumab in Treatment of Select Refractory or Metastatic Cancers
VE800 plus nivolumab was well tolerated but offered no improvement over historic response rates.
PreprintUso en el mundo realPhase I Clinical Trial of Allogeneic Cytomegalovirus-specific T Cells in Combination with Pembrolizumab for Recurrent Glioblastoma
Conclusions: Allogeneic CMV-specific T-cell therapy combined with pembrolizumab was safe in recurrent GBM, supporting further evaluation of this strategy to overcome immune dysfunction in GBM.
PreprintUso en el mundo realFeasibility and Psychological Outcomes of a Clinical Meditation Intervention for Patients with Cancer: A Mixed-Methods Pilot Study
ConclusionsThis mixed-methods pilot study suggests that Clinical Meditation may be feasible and acceptable for patients with cancer, although sustaining meditation practice remains challenging.
PreprintUso en el mundo realPerioperative Safety, Surgical Morbidity, and Survival Outcomes of Neoadjuvant Chemotherapy (NACT-IDS) versus Primary Debulking Surgery (PDS) in Elderly Patients with Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis
Conclusion: For older women with advanced epithelial ovarian cancer, NACT-IDS significantly improves perioperative safety, accelerates hospital recovery, and maximizes complete resection rates compared to upfront PDS.
PreprintAfirmaciones fuertes, leer con cuidadoUso en el mundo real